Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: J Am Coll Surg. 2014 Dec 17;220(4):497–508. doi: 10.1016/j.jamcollsurg.2014.12.013

Table 2. Complications among Resected Pancreatic and Periampullary Adenocarcinoma Patients.

Total (n=387) Ethanol (n=193) Saline (n=194) p Value
Complications, any 85 (44%) 82 (42%) 0.75*
Complication type
 Pancreatic fistula 22 (11%) 33 (17%) 0.12*
 DGE 41 (21%) 33 (17%) 0.29*
 Intra-abdominal abscess 15 (8%) 22 (11%) 0.24*
 Wound infection 12 (6%) 17 (9%) 0.33*
 UTI 16 (8%) 13 (7%) 0.58*
 Cardiac 12 (6%) 11 (6%) 0.83*
 HJ or DJ leak 6 (3%) 9 (5%) 0.42*
 Other 9 (5%) 8 (4%) 0.77*
No. of complications per patient, mean 0.7 0.8 0.28
LOS, d (median, range; Q1, Q3) 7 (6, 10) 7 (6, 8)
30-d Mortality, n (%) 4 (2.1) 3 (1.5) 0.66*
90-d Mortality, n (%) 4 (2.1) 7 (3.6) 0.37*

Fistula grading per ISGPF criteria.

*

Cochran-Mantel-Haenszel: row mean scores difference p-value.

Zero-Inflated Poisson: treatment group p-value.

DGE, delayed gastric emptying; UTI, urinary tract infection; DVT, deep venous thrombosis; HJ, hepaticojejunostomy; DJ, duodenojejunostomy; LOS, postoperative hospital length of stay.